Open Access
Open access
Cell Chemical Biology, volume 25, issue 12, pages 1506-1518.e13

Tetracyclines Modify Translation by Targeting Key Human rRNA Substructures

Mortison Jonathan D 1
Schenone Mónica 2
Myers Jacob A. 1
Zhang Ziyang 1
Chen Linfeng 1
Ciarlo Christie 2
Comer Eamon 2
Natchiar S. Kundhavai 3
Carr Steven 2
Klaholz B.P. 3
Myers Andrew T. 1
1
 
Dept. of Chemistry and Chemical Biology, Harvard University, Cambridge, MA 02138, USA.
3
 
Centre for Integrative Biology (CBI), Department of Integrated Structural Biology, IGBMC (Institute of Genetics and of Molecular and Cellular Biology), 1 Rue Laurent Fries, Illkirch 67404, France
Publication typeJournal Article
Publication date2018-12-01
Quartile SCImago
Q1
Quartile WOS
Q1
Impact factor8.6
ISSN24519448, 24519456
Drug Discovery
Biochemistry
Molecular Biology
Pharmacology
Clinical Biochemistry
Molecular Medicine
Abstract
Apart from their antimicrobial properties, tetracyclines demonstrate clinically validated effects in the amelioration of pathological inflammation and human cancer. Delineation of the target(s) and mechanism(s) responsible for these effects, however, has remained elusive. Here, employing quantitative mass spectrometry-based proteomics, we identified human 80S ribosomes as targets of the tetracyclines Col-3 and doxycycline. We then developed in-cell click selective crosslinking with RNA sequence profiling (icCL-seq) to map binding sites for these tetracyclines on key human rRNA substructures at nucleotide resolution. Importantly, we found that structurally and phenotypically variant tetracycline analogs could chemically discriminate these rRNA binding sites. We also found that tetracyclines both subtly modify human ribosomal translation and selectively activate the cellular integrated stress response (ISR). Together, the data reveal that targeting of specific rRNA substructures, activation of the ISR, and inhibition of translation are correlated with the anti-proliferative properties of tetracyclines in human cancer cell lines.

Citations by journals

1
Nature Chemical Biology
Nature Chemical Biology, 1, 2.94%
Nature Chemical Biology
1 publication, 2.94%
Open Biochemistry Journal
Open Biochemistry Journal, 1, 2.94%
Open Biochemistry Journal
1 publication, 2.94%
Cells
Cells, 1, 2.94%
Cells
1 publication, 2.94%
Journal of Personalized Medicine
Journal of Personalized Medicine, 1, 2.94%
Journal of Personalized Medicine
1 publication, 2.94%
Frontiers in Physiology
Frontiers in Physiology, 1, 2.94%
Frontiers in Physiology
1 publication, 2.94%
Frontiers in Pharmacology
Frontiers in Pharmacology, 1, 2.94%
Frontiers in Pharmacology
1 publication, 2.94%
Nature Communications
Nature Communications, 1, 2.94%
Nature Communications
1 publication, 2.94%
Nature Reviews Drug Discovery
Nature Reviews Drug Discovery, 1, 2.94%
Nature Reviews Drug Discovery
1 publication, 2.94%
Scientific Reports
Scientific Reports, 1, 2.94%
Scientific Reports
1 publication, 2.94%
Infection
Infection, 1, 2.94%
Infection
1 publication, 2.94%
Antiviral Research
Antiviral Research, 1, 2.94%
Antiviral Research
1 publication, 2.94%
Methods
Methods, 1, 2.94%
Methods
1 publication, 2.94%
PLoS Genetics
PLoS Genetics, 1, 2.94%
PLoS Genetics
1 publication, 2.94%
Biomedicine and Pharmacotherapy
Biomedicine and Pharmacotherapy, 1, 2.94%
Biomedicine and Pharmacotherapy
1 publication, 2.94%
SLAS Discovery
SLAS Discovery, 1, 2.94%
SLAS Discovery
1 publication, 2.94%
Cell Chemical Biology
Cell Chemical Biology, 1, 2.94%
Cell Chemical Biology
1 publication, 2.94%
FEBS Journal
FEBS Journal, 1, 2.94%
FEBS Journal
1 publication, 2.94%
Andrologia
Andrologia, 1, 2.94%
Andrologia
1 publication, 2.94%
ACS Medicinal Chemistry Letters
ACS Medicinal Chemistry Letters, 1, 2.94%
ACS Medicinal Chemistry Letters
1 publication, 2.94%
ACS Chemical Biology
ACS Chemical Biology, 1, 2.94%
ACS Chemical Biology
1 publication, 2.94%
Journal of the American Chemical Society
Journal of the American Chemical Society, 1, 2.94%
Journal of the American Chemical Society
1 publication, 2.94%
Antioxidants
Antioxidants, 1, 2.94%
Antioxidants
1 publication, 2.94%
Cancers
Cancers, 1, 2.94%
Cancers
1 publication, 2.94%
Organic and Biomolecular Chemistry
Organic and Biomolecular Chemistry, 1, 2.94%
Organic and Biomolecular Chemistry
1 publication, 2.94%
Biochemistry (Moscow)
Biochemistry (Moscow), 1, 2.94%
Biochemistry (Moscow)
1 publication, 2.94%
Expert Review of Anti-Infective Therapy
Expert Review of Anti-Infective Therapy, 1, 2.94%
Expert Review of Anti-Infective Therapy
1 publication, 2.94%
eLife
eLife, 1, 2.94%
eLife
1 publication, 2.94%
Israel Journal of Chemistry
Israel Journal of Chemistry, 1, 2.94%
Israel Journal of Chemistry
1 publication, 2.94%
Infection and Immunity
Infection and Immunity, 1, 2.94%
Infection and Immunity
1 publication, 2.94%
1

Citations by publishers

1
2
3
4
5
6
Springer Nature
Springer Nature, 6, 17.65%
Springer Nature
6 publications, 17.65%
Multidisciplinary Digital Publishing Institute (MDPI)
Multidisciplinary Digital Publishing Institute (MDPI), 4, 11.76%
Multidisciplinary Digital Publishing Institute (MDPI)
4 publications, 11.76%
Elsevier
Elsevier, 4, 11.76%
Elsevier
4 publications, 11.76%
Wiley
Wiley, 3, 8.82%
Wiley
3 publications, 8.82%
American Chemical Society (ACS)
American Chemical Society (ACS), 3, 8.82%
American Chemical Society (ACS)
3 publications, 8.82%
Frontiers Media S.A.
Frontiers Media S.A., 2, 5.88%
Frontiers Media S.A.
2 publications, 5.88%
Bentham Science
Bentham Science, 1, 2.94%
Bentham Science
1 publication, 2.94%
Public Library of Science (PLoS)
Public Library of Science (PLoS), 1, 2.94%
Public Library of Science (PLoS)
1 publication, 2.94%
SAGE
SAGE, 1, 2.94%
SAGE
1 publication, 2.94%
Royal Society of Chemistry (RSC)
Royal Society of Chemistry (RSC), 1, 2.94%
Royal Society of Chemistry (RSC)
1 publication, 2.94%
Pleiades Publishing
Pleiades Publishing, 1, 2.94%
Pleiades Publishing
1 publication, 2.94%
Taylor & Francis
Taylor & Francis, 1, 2.94%
Taylor & Francis
1 publication, 2.94%
eLife Sciences Publications
eLife Sciences Publications, 1, 2.94%
eLife Sciences Publications
1 publication, 2.94%
American Society for Microbiology
American Society for Microbiology, 1, 2.94%
American Society for Microbiology
1 publication, 2.94%
1
2
3
4
5
6
  • We do not take into account publications that without a DOI.
  • Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
  • Statistics recalculated weekly.
Metrics
Share
Cite this
GOST |
Cite this
GOST Copy
Mortison J. D. et al. Tetracyclines Modify Translation by Targeting Key Human rRNA Substructures // Cell Chemical Biology. 2018. Vol. 25. No. 12. p. 1506-1518.e13.
GOST all authors (up to 50) Copy
Mortison J. D., Schenone M., Myers J. A., Zhang Z., Chen L., Ciarlo C., Comer E., Natchiar S. K., Carr S., Klaholz B., Myers A. T. Tetracyclines Modify Translation by Targeting Key Human rRNA Substructures // Cell Chemical Biology. 2018. Vol. 25. No. 12. p. 1506-1518.e13.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1016/j.chembiol.2018.09.010
UR - https://doi.org/10.1016%2Fj.chembiol.2018.09.010
TI - Tetracyclines Modify Translation by Targeting Key Human rRNA Substructures
T2 - Cell Chemical Biology
AU - Mortison, Jonathan D
AU - Schenone, Mónica
AU - Myers, Jacob A.
AU - Zhang, Ziyang
AU - Chen, Linfeng
AU - Ciarlo, Christie
AU - Comer, Eamon
AU - Natchiar, S. Kundhavai
AU - Carr, Steven
AU - Klaholz, B.P.
AU - Myers, Andrew T.
PY - 2018
DA - 2018/12/01 00:00:00
PB - Elsevier
SP - 1506-1518.e13
IS - 12
VL - 25
PMID - 30318461
SN - 2451-9448
SN - 2451-9456
ER -
BibTex |
Cite this
BibTex Copy
@article{2018_Mortison,
author = {Jonathan D Mortison and Mónica Schenone and Jacob A. Myers and Ziyang Zhang and Linfeng Chen and Christie Ciarlo and Eamon Comer and S. Kundhavai Natchiar and Steven Carr and B.P. Klaholz and Andrew T. Myers},
title = {Tetracyclines Modify Translation by Targeting Key Human rRNA Substructures},
journal = {Cell Chemical Biology},
year = {2018},
volume = {25},
publisher = {Elsevier},
month = {dec},
url = {https://doi.org/10.1016%2Fj.chembiol.2018.09.010},
number = {12},
pages = {1506--1518.e13},
doi = {10.1016/j.chembiol.2018.09.010}
}
MLA
Cite this
MLA Copy
Mortison, Jonathan D., et al. “Tetracyclines Modify Translation by Targeting Key Human rRNA Substructures.” Cell Chemical Biology, vol. 25, no. 12, Dec. 2018, pp. 1506-1518.e13. https://doi.org/10.1016%2Fj.chembiol.2018.09.010.
Found error?